Connection

Richard Rissmiller to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Richard Rissmiller has written about Clinical Trials, Phase III as Topic.
Richard Rissmiller
Connection Strength
0.030
Clinical Trials, Phase III as Topic
  1. Riociguat: a novel new drug for treatment of pulmonary hypertension. Pharmacotherapy. 2015 May; 35(5):502-19.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.